FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11506511000001108: Oxandrin 2.5mg tablets (CSL Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42259401000001119 Oxandrin 2.5mg tablets (CSL Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43207501000001111 Oxandrin 2.5mg tablets (Imported (Australia)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxandrin 2.5mg tablets (CSL Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Anab) true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Is a Product containing precisely oxandrolone 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has active ingredient Oxandrolone false Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has specific active ingredient Oxandrolone true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oxandrin 2.5mg tablets (CSL Ltd) 100 tablet Is pack of False Oxandrin 2.5mg tablets (CSL Ltd) Inferred relationship Existential restriction modifier
Oxandrin 2.5mg tablets (CSL Ltd) 100 tablet Has AMP True Oxandrin 2.5mg tablets (CSL Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start